Researchers Identify Two Key Proteins That Control Heart Growth

Researchers have identified how two proteins control the growth of the heart and its adaptation to high blood pressure.

The heart adapts to the changing needs of each stage of life by adjusting its size. In this way the heart grows in line with the rest of our body, including during pregnancy, in a process called cardiac hypertrohpy. However, excessive physical exercise, hypertension and obesity can trigger excessive heart growth (pathological hypertrophy), a situation that can lead to a heart attack.

Understanding the molecular processes that regulate heart function and growth is, therefore, of immense importance. Researchers have now identified how two proteins control the growth of the heart and its adaptation to high blood pressure that can help design new strategies to treat heart failure caused by excessive growth of the heart.

Cardiac Pacemaker for Abnormal Heart Rhythms – Types, Advantages & Risks
A pacemaker stimulates the heart with electrical signals when it detects arrhythmias of the heart. Pacemakers are classified based on the number of lead electrodes used and the type of pacing involved.

‘Two proteins, p38 gamma and p38 delta, regulate the growth of the left ventricle - the largest and strongest heart chamber - responsible for pumping oxygenated blood to the body.’

The research, carried out by lead investigator Guadalupe Sabio from the National Center for Cardiovascular Research (CNIC) in Spain, shows for the first time that two proteins - p38 gamma and p38 delta - control heart growth.

"This new information could help in the design of new strategies to combat heart conditions caused by anomalous growth of heart muscle," said Sabio in a paper in Nature Communications.

Sabio's team found that p38 gamma and p38 delta regulate the growth of the left ventricle - the largest and strongest heart chamber - responsible for pumping oxygenated blood to the body.

Congestive Heart Failure (Congestive Cardiac Failure) Current Management
Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump that can deliver oxygen rich blood to the body.

The research team showed that the hearts of mice lacking these proteins are smaller than normal.

These hearts, although they function normally, are incapable of responding to external stimuli, such as high blood pressure.

Men, Women may Need Gender-Specific Heart Failure Treatment
Johns Hopkins scientists shed light on different forms of heart failure seen in men and women that may require the development of gender-specific treatments.

The discovery advances understanding of the mechanisms through which heart cells grow and adapt.

Source-IANS

Research Sheds Light on the Misunderstood Rambo Protein That Limits Heart Failure
The discovery of the Rambo protein's importance in protecting cells represents a significant step forward in the understanding of disease processes.